Cryopreserved, xeno-free human umbilical cord mesenchymal stromal cells reduce lung injury severity and bacterial burden in rodent Escherichia coli -induced acute respiratory distress syndrome

Critical Care Medicine

Volumn 45, Issue 2, 2017, Pages e202-e212

  Curley, Gerard F ^a,b,c   Jerkic, Mirjana ^b   Dixon, Steve ^b   Hogan, Grace ^b   Masterson, Claire ^b   O'toole, Daniel ^d   Devaney, James ^d   Laffey, John G ^a,b,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

acute respiratory distress syndrome; mesenchymal stem stromal cells; oxidative stress; sepsis; umbilical cord

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; SERUM-FREE MEDIUM;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CONTROLLED STUDY; CRYOPRESERVATION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; INJURY SEVERITY; LUNG LAVAGE; MALE; MESENCHYMAL STROMA CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RAT MODEL; UMBILICAL CORD; ANIMAL; COMPLICATION; CYTOLOGY; DISEASE MODEL; ESCHERICHIA COLI INFECTION; LUNG INJURY; MESENCHYMAL STEM CELL TRANSPLANTATION; PHYSIOLOGY; PNEUMONIA, BACTERIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SERUM-FREE MEDIUM; SPRAGUE DAWLEY RAT;

ANIMALS; CULTURE MEDIA, SERUM-FREE; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; HUMANS; LUNG INJURY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; OXIDATIVE STRESS; PNEUMONIA, BACTERIAL; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY DISTRESS SYNDROME, ADULT; UMBILICAL CORD;

EID: 84995744045     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002073     Document Type: Article

References (62)

1. Ortiz LA, Gambelli F, McBride C, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 2003; 100: 8407-8411
2. Xu J, Woods CR, Mora AL, et al. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 2007; 293: L131-L141
3. Gupta N, Su X, Popov B, et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007; 179: 1855-1863
4. Mei SH, Haitsma JJ, Dos Santos CC, et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 2010; 182: 1047-1057
5. Németh K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15: 42-49
6. van Haaften T, Byrne R, Bonnet S, et al. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 2009; 180: 1131-1142
7. Aslam M, Baveja R, Liang OD, et al. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 2009; 180: 1122-1130
8. Curley GF, Hayes M, Ansari B, et al. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax 2012; 67: 496-501
9. Devaney J, Horie S, Masterson C, et al. Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat. Thorax 2015; 70: 625-635
10. Curley GF, Ansari B, Hayes M, et al. Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury. Anesthesiology 2013; 118: 924-932
11. Williams AR, Hare JM. Mesenchymal stem cells: Biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 2011; 109: 923-940
12. Jones E, Yang X. Mesenchymal stem cells and bone regeneration: Current status. Injury 2011; 42: 562-568
13. Maumus M, Guérit D, Toupet K, et al. Mesenchymal stem cell-based therapies in regenerative medicine: Applications in rheumatology. Stem Cell Res Ther 2011; 2: 14
14. Auletta JJ, Deans RJ, Bartholomew AM. Emerging roles for multipotent, bone marrow-derived stromal cells in host defense. Blood 2012; 119: 1801-1809
15. Dazzi F, Lopes L, Weng L. Mesenchymal stromal cells: A key player in innate tolerance?. Immunology 2012; 137: 206-213
16. Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol 2012; 12: 383-396
17. Wilson JG, Liu KD, Zhuo H, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: A phase 1 clinical trial. Lancet Respir Med 2015; 3: 24-32
18. Galipeau J. The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroidresistant graft-versus-host disease represent a death knell or a bump in the road?. Cytotherapy 2013; 15: 2-8
19. Digirolamo CM, Stokes D, Colter D, et al. Propagation and senescence of human marrow stromal cells in culture: A simple colonyforming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 1999; 107: 275-281
20. Hua J, Gong J, Meng H, et al. Comparison of different methods for the isolation of mesenchymal stem cells from umbilical cord matrix: Proliferation and multilineage differentiation as compared to mesenchymal stem cells from umbilical cord blood and bone marrow. Cell Biol Int 2014; 38: 198-210
21. Fong CY, Gauthaman K, Cheyyatraivendran S, et al. Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo. J Cell Biochem 2012; 113: 658-668
22. Dimarakis I, Levicar N. Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 2006; 24: 1407-1408
23. Sundin M, Ringdén O, Sundberg B, et al. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 2007; 92: 1208-1215
24. Mackensen A, Dräger R, Schlesier M, et al. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol Immunother 2000; 49: 152-156
25. Selvaggi TA, Walker RE, Fleisher TA. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 1997; 89: 776-779
26. Tuschong L, Soenen SL, Blaese RM, et al. Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther 2002; 13: 1605-1610
27. O'Croinin DF, Nichol AD, Hopkins N, et al. Sustained hypercapnic acidosis during pulmonary infection increases bacterial load and worsens lung injury. Crit Care Med 2008; 36: 2128-2135
28. Curley GF, Contreras M, Higgins B, et al. Evolution of the inflammatory and fibroproliferative responses during resolution and repair after ventilator-induced lung injury in the rat. Anesthesiology 2011; 115: 1022-1032
29. Higgins BD, Costello J, Contreras M, et al. Differential effects of buffered hypercapnia versus hypercapnic acidosis on shock and lung injury induced by systemic sepsis. Anesthesiology 2009; 111: 1317-1326
30. Costello J, Higgins B, Contreras M, et al. Hypercapnic acidosis attenuates shock and lung injury in early and prolonged systemic sepsis. Crit Care Med 2009; 37: 2412-2420
31. Laffey JG, Honan D, Hopkins N, et al. Hypercapnic acidosis attenuates endotoxin-induced acute lung injury. Am J Respir Crit Care Med 2004; 169: 46-56
32. Howell K, Preston RJ, McLoughlin P. Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation. J Physiol 2003; 547: 133-145
33. Hopkins N, Cadogan E, Giles S, et al. Chronic airway infection leads to angiogenesis in the pulmonary circulation. J Appl Physiol (1985) 2001; 91: 919-928
34. Jerkic M, Peter M, Ardelean D, et al. Dextran sulfate sodium leads to chronic colitis and pathological angiogenesis in Endoglin heterozygous mice. Inflamm Bowel Dis 2010; 16: 1859-1870
35. Hayes M, Masterson C, Devaney J, et al. Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilator-induced lung injury in the rat. Anesthesiology 2015; 122: 363-373
36. Gleeson BM, Martin K, Ali MT, et al. Bone marrow-derived mesenchymal stem cells have innate procoagulant activity and cause microvascular obstruction following intracoronary delivery: Amelioration by antithrombin therapy. Stem Cells 2015; 33: 2726-2737
37. Ryan AE, Lohan P, O'Flynn L, et al. Chondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation. Mol Ther 2014; 22: 655-667
38. Lee JW, Krasnodembskaya A, McKenna DH, et al. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am J Respir Crit Care Med 2013; 187: 751-760
39. McAuley DF, Curley GF, Hamid UI, et al. Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. Am J Physiol Lung Cell Mol Physiol 2014; 306: L809-L815
40. D'Ippolito G, Schiller PC, Ricordi C, et al. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999; 14: 1115-1122
41. Trounson A, McDonald C. Stem Cell Therapies in Clinical Trials: Progress and Challenges. Cell Stem Cell 2015; 17: 11-22
42. von Bahr L, Sundberg B, Lönnies L, et al. Long-Term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. Biol Blood Marrow Transplant 2012; 18: 557-564
43. Ahn SY, Chang YS, Sung DK, et al. Cell type-dependent variation in paracrine potency determines therapeutic efficacy against neonatal hyperoxic lung injury. Cytotherapy 2015; 17: 1025-1035
44. Liu L, Mao Q, Chu S, et al. Intranasal versus intraperitoneal delivery of human umbilical cord tissue-derived cultured mesenchymal stromal cells in a murine model of neonatal lung injury. Am J Pathol 2014; 184: 3344-3358
45. Pierro M, Ionescu L, Montemurro T, et al. Short-Term, long-Term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax 2013; 68: 475-484
46. Chang YS, Ahn SY, Yoo HS, et al. Mesenchymal stem cells for bronchopulmonary dysplasia: Phase 1 dose-escalation clinical trial. J Pediatr 2014; 164: 966-972.e6
47. Kim ES, Chang YS, Choi SJ, et al. Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells attenuates Escherichia coli-induced acute lung injury in mice. Respir Res 2011; 12: 108
48. Sun J, Han ZB, Liao W, et al. Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4+CD25+ Forkhead Boxp3 (FOXP3)+ regulatory T cells and balancing anti- And pro-inflammatory factors. Cell Physiol Biochem 2011; 27: 587-596
49. Li J, Li D, Liu X, et al. Human umbilical cord mesenchymal stem cells reduce systemic inflammation and attenuate LPS-induced acute lung injury in rats. J Inflamm (Lond) 2012; 9: 33
50. Mannam P, Srivastava A, Sugunaraj JP, et al. Oxidants in acute and chronic lung disease. J Blood Lymph 2014; 4
51. Babior BM, Lambeth JD, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 2002; 397: 342-344
52. Rinaldo JE. Mediation of ARDS by leukocytes. Clinical evidence and implications for therapy. Chest 1986; 89: 590-593
53. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2001; 2: 907-916
54. Carnesecchi S, Pache JC, Barazzone-Argiroffo C. NOX enzymes: Potential target for the treatment of acute lung injury. Cell Mol Life Sci 2012; 69: 2373-2385
55. Su CF, Kao SJ, Chen HI. Acute respiratory distress syndrome and lung injury: Pathogenetic mechanism and therapeutic implication. World J Crit Care Med 2012; 1: 50-60
56. Cross AR, Segal AW. The NADPH oxidase of professional phagocytes-prototype of the NOX electron transport chain systems. Biochim Biophys Acta 2004; 1657: 1-22
57. Wang L, Taneja R, Razavi HM, et al. Specific role of neutrophil inducible nitric oxide synthase in murine sepsis-induced lung injury in vivo. Shock 2012; 37: 539-547
58. Valle-Prieto A, Conget PA. Human mesenchymal stem cells efficiently manage oxidative stress. Stem Cells Dev 2010; 19: 1885-1893
59. Horwitz EM, Gordon PL, Koo WK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 2002; 99: 8932-8937
60. Ylostalo JH, Bartosh TJ, Tiblow A, et al. Unique characteristics of human mesenchymal stromal/progenitor cells pre-Activated in 3-dimensional cultures under different conditions. Cytotherapy 2014; 16: 1486-1500
61. Fang X, Abbott J, Cheng L, et al. Human mesenchymal stem (stromal) cells promote the resolution of acute lung injury in part through lipoxin A4. J Immunol 2015; 195: 875-881
62. Monsel A, Zhu YG, Gennai S, et al. Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice. Am J Respir Crit Care Med 2015; 192: 324-336